Alexandria Leigh Dougherty, Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 1021 Old York Rd Ste 301, Abington, PA 19001 Phone: 215-395-8266 Fax: 215-754-0989 |
Nicholas Gregory Ciminera, CRNP Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-4100 |
Eunice Olayinka Itabiyi, NP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 1111 Highland Ave, Abington, PA 19001 Phone: 347-898-1413 |
Christine Angela Sherk, Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 |
Nae'emah Renee Clark, CRNP Nurse Practitioner - Women's Health Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2111 |
News Archive
There is plenty to worry about when it comes to the job of parenting. However, wondering if a child is receiving the correct amount of over-the-counter (OTC) medication can now be a concern of the past, thanks to Children's AccuDial(R), a patented new line of children's medication available across Canada, with a dosing system based on body weight, not age.
An editorial published online November 20 in the Journal of the National Cancer Institute discusses the exaggerated fears and hopes that often appear in news coverage of cancer research. The editorial provides guidance for both the media and journals to help alleviate the problem.
A disturbing new study details an increase in vaccine hesitancy among many Australians over the period of August 2020 to January 2021. This may have serious implications for the country's ability to achieve universal immunization.
The genetic material of DNA contains shielding mechanisms to protect itself from the exposure to the UV light emitted by the sun. This is of crucial importance, since without photostability i.e. without programmed defense mechanisms against UV irradiation a rapid degradation of DNA and RNA would be the consequence. As part of a project funded by the Austrian Science Fund (FWF) a group of researchers led by Hans Lischka, Quantum Chemist of the University of Vienna, Austria, could, for the first time, comprehensively unravel these ultra-fast processes of the photostability of the nucleobases.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
› Verified 9 days ago